Swedish-Nature-06-1248x672-1

Bioanalytical Services

Answering to the complexities of large molecules

plate-detail-504x672

Answering to the complexities of large molecules

Bioanalytical Services

 As a trusted bioanalytical service partner, we facilitate your work and help accelerate your drug development process through tailored solutions and a uniquely consultative approach. Our GCP and GLP-compliant laboratory delivers bioanalytical collaborative excellence in every project.

Bioanalytical Service Solutions

We support all stages of drug development, from preclinical studies through clinical phases I–III and post-marketing activities, offering a unique combination of off-the-shelf products and custom services. Our capabilities include method transfer, de novo assay development, assay validation, and sample analysis.

elisa

Ligand-Binding Assays

ELISA, MSD®-ECL, Simoa® bead technology

ilite

Cell-Based Assays

Including our proprietary iLite® technology

ms

Mass Spectrometry

Through our partner Lablytica Life Science

Modalities

Bioanalytical modalities
Large molecule analysis
Monoclonal antibodies (mAbs), therapeutic proteins, biosimilars, antibody-drug conjugates (ADCs)
Bioanalytical modalities
Small molecules
Through our partner Lablytica Life Science
Bioanalytical modalities
Vector-based therapies
AAV-based therapies

Our Bioanalytical Services

At Svar, we leverage our extensive bioanalytical expertise and a wide range of technologies to deliver high-quality studies tailored to your needs. We constantly innovate, developing and validating new methods to improve efficiency and reliability, ensuring we meet the evolving challenges of drug development.

  • Bioanalytical Service

    Toxicology is the branch of pharmacology that studies the behavior and effects of compounds at very high doses in an organism. The goal of toxicokinetic (TK) studies is to determine the exposure levels at which toxic effects are observed, and results are used to guide dosing recommendations for clinical testing.

    We conduct TK analysis in strict compliance with GLP regulations and in accordance with international regulatory guidelines (FDA, EMEA, ICH).

    Instrumentation:

    • ELISA
    • MSD®-ECL
    • LC-MS/MS

    Contact us to get started

  • Bioanalytical Service

    Pharmacokinetics (PK) reveals how a therapy moves through the body—from absorption and distribution to metabolism and excretion—and translates those dynamics into actionable decisions for development.

    In the drug development process, robust PK data underpins dose selection, route and frequency of administration, and the transition from preclinical models to first-in-human and late-stage trials.

    We deliver end-to-end PK support across drug modalities at any phase of development, combining deep bioanalytical experience with regulatory expectations.

    Instrumentation:

    • ELISA
    • MSD®-ECL
    • LC-MS/MS

    Contact us to get started

  • Bioanalytical Service

    Pharmacodynamics studies focus on the biochemical and physiological effects of the drug on the patient and are crucial to ensure a complete understanding of the therapeutic product.

    Large molecule PD bioanalysis provides insights into the mechanism of action and how the drug works on a biochemical level. PD bioanalytical studies can be used to investigate what molecules bind, how the targets are inhibited, what signaling pathway is affected, and to identify downstream effects.

    Instrumentation:

    • ELISA
    • MSD®-ECL
    • Cell-based assays
    • LC-MS/MS

    Contact us to get started

  • Bioanalytical Service

    Immunogenicity is a critical factor in drug development., as unwanted immune responses, from minimal effects to severe and life-threatening reactions, can impact both safety and efficacy. Regulatory guidelines require thorough evaluation of immunogenicity for biologics and biosimilars.

    With extensive experience, we offer a multi-tiered approach using advanced assays to detect and confirm anti-drug antibodies (ADAs) and neutralizing antibodies (NAbs) across preclinical and clinical studies.

    Instrumentation

    • ELISA
    • MSD®-ECL
    • Cell-based assays

    Contact us to get started

  • Bioanalytical Service

    In drug development, biomarker analysis supports the assessment of candidate drugs. Biomarkers can be used to validate targets, prove mechanisms of action, predict efficacy, and find potential toxicity, enabling go/no-go decisions during the drug development process.

    We offer a complete biomarker service tailored to your drug development project. Our approach ensures that every assay is developed with a clear context of use and is fit-for-purpose, providing reliable data to support decision-making at each stage. 

    Instrumentation:

    • ELISA
    • MSD®-ECL
    • SIMOA®
    • LC-MS/MS
    • Cell-based assays

    Contact us to get started

  • Bioanalytical Service

    Through Svar Wieslab Diagnostic Service, we offer a comprehensive range of individual tests and test panels that support clinical testing and therapeutic drug monitoring.

    With flexible, tailored diagnostics and responsive service, Svar Wieslab combines clinical expertise and ISO 15189-certified rigor to deliver timely and accurate results.

    Contact us to get started

  • Bioanalytical Service

    We offer expert consulting for large molecule preclinical and clinical studies, helping you design optimal bioanalytical strategies to accelerate drug discovery and development. Our scientist-to-scientist approach ensures tailored solutions for your toughest assay challenges. By understanding your molecular targets, pharmacokinetics, and lead molecules, we identify risks and opportunities to drive improvement.

    Contact us to get started

25+
years of laboratory experience

450+
completed projects

60+
satisfied customers

20+
successful audits over the last 4 years

Results you can trust

At Svar CRO Services, we share your passion for drug discovery and development and aim to fully accommodate your needs through end-to-end customizable solutions.

High-quality assay methodologies

Get high-quality assay methodologies and results, rigorously adhering to GLP and GCP regulations as well as international regulatory standards (ICH, OECD, EMA, FDA).

Comprehensively characterized methods

Our services team uses comprehensively characterized, fully validated, and meticulously documented bioanalytical methods for consistent and reliable results.

Assay development experience

We have extensive experience in developing and validating assays throughout all phases of drug development.

Multi-organism support

We offer support in studies involving different organisms – including rodents, humans, and nonhuman primates.

Multi-tiered immunogenicity testing

Our team uses a multi-tiered approach to immunogenicity testing. We assist in designing customized cell-based solutions for NAb assays.

Proprietary products & custom methods

We use proprietary off-the-shelf products and custom method development for cell-based and immunoassays with in-house R&D capabilities.

CRO Services News

previous
Svar Life Science & Lablytica Life Science Announce Strategic Partnership

25 JANUARY 2026

Svar Life Science & Lablytica Life Science Announce Strategic Partnership

Read post
next

Contact our CRO Services team

Write us a message and a service specialist will get in touch